292 related articles for article (PubMed ID: 29562821)
21. The iron chelator deferasirox induces apoptosis by targeting oncogenic Pyk2/β-catenin signaling in human multiple myeloma.
Kamihara Y; Takada K; Sato T; Kawano Y; Murase K; Arihara Y; Kikuchi S; Hayasaka N; Usami M; Iyama S; Miyanishi K; Sato Y; Kobune M; Kato J
Oncotarget; 2016 Sep; 7(39):64330-64341. PubMed ID: 27602957
[TBL] [Abstract][Full Text] [Related]
22. Decreased Iron in Cancer Cells and Their Microenvironment Improves Cytolysis of Breast Cancer Cells by Natural Killer Cells.
Jiang XP; Elliott RL
Anticancer Res; 2017 May; 37(5):2297-2305. PubMed ID: 28476795
[TBL] [Abstract][Full Text] [Related]
23. Targeted Co-delivery of the Iron Chelator Deferoxamine and a HIF1α Inhibitor Impairs Pancreatic Tumor Growth.
Lang J; Zhao X; Wang X; Zhao Y; Li Y; Zhao R; Cheng K; Li Y; Han X; Zheng X; Qin H; Geranpayehvaghei M; Shi J; Anderson GJ; Hao J; Ren H; Nie G
ACS Nano; 2019 Feb; 13(2):2176-2189. PubMed ID: 30676731
[TBL] [Abstract][Full Text] [Related]
24. Effect of the FE
Bernardes JR; Faria CC; Andrade IS; Ferreira ACF; Carvalho DP; Leitão AC; de Alencar TAM; Fortunato RS
Life Sci; 2018 Jan; 192():128-135. PubMed ID: 29180001
[TBL] [Abstract][Full Text] [Related]
25. Deferoxamine pre-treatment protects against postoperative cognitive dysfunction of aged rats by depressing microglial activation via ameliorating iron accumulation in hippocampus.
Pan K; Li X; Chen Y; Zhu D; Li Y; Tao G; Zuo Z
Neuropharmacology; 2016 Dec; 111():180-194. PubMed ID: 27608977
[TBL] [Abstract][Full Text] [Related]
26. The role of Iron on breast cancer stem-like cells.
Ozer U
Cell Mol Biol (Noisy-le-grand); 2016 Apr; 62(4):25-30. PubMed ID: 27188730
[TBL] [Abstract][Full Text] [Related]
27. Iron chelation cancer therapy using hydrophilic block copolymers conjugated with deferoxamine.
Komoto K; Nomoto T; El Muttaqien S; Takemoto H; Matsui M; Miura Y; Nishiyama N
Cancer Sci; 2021 Jan; 112(1):410-421. PubMed ID: 32770631
[TBL] [Abstract][Full Text] [Related]
28. [Deferoxamine induces apoptosis of K562 cells].
Jia GC; Tang YC; Li FY; Liao QK
Zhongguo Dang Dai Er Ke Za Zhi; 2011 Aug; 13(8):674-6. PubMed ID: 21849122
[TBL] [Abstract][Full Text] [Related]
29. The iron metabolism of the human neuroblastoma cell: lack of relationship between the efficacy of iron chelation and the inhibition of DNA synthesis.
Richardson DR; Ponka P
J Lab Clin Med; 1994 Nov; 124(5):660-71. PubMed ID: 7964124
[TBL] [Abstract][Full Text] [Related]
30. Benefits of Iron Chelators in the Treatment of Parkinson's Disease.
Zeng X; An H; Yu F; Wang K; Zheng L; Zhou W; Bao Y; Yang J; Shen N; Huang D
Neurochem Res; 2021 May; 46(5):1239-1251. PubMed ID: 33646533
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of N-myc expression and induction of apoptosis by iron chelation in human neuroblastoma cells.
Fan L; Iyer J; Zhu S; Frick KK; Wada RK; Eskenazi AE; Berg PE; Ikegaki N; Kennett RH; Frantz CN
Cancer Res; 2001 Feb; 61(3):1073-9. PubMed ID: 11221835
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of growth of human breast carcinoma cells by an antisense oligonucleotide targeted to the transferrin receptor gene.
Yang DC; Jiang XP; Elliott RL; Head JF
Anticancer Res; 2001; 21(3B):1777-87. PubMed ID: 11497259
[TBL] [Abstract][Full Text] [Related]
33.
Menghini S; Ho PS; Gwisai T; Schuerle S
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33419059
[TBL] [Abstract][Full Text] [Related]
34. Changes in gene expression with iron loading and chelation in cardiac myocytes and non-myocytic fibroblasts.
Parkes JG; Liu Y; Sirna JB; Templeton DM
J Mol Cell Cardiol; 2000 Feb; 32(2):233-46. PubMed ID: 10722800
[TBL] [Abstract][Full Text] [Related]
35. Lipid accumulation in human breast cancer cells injured by iron depletors.
De Bortoli M; Taverna E; Maffioli E; Casalini P; Crisafi F; Kumar V; Caccia C; Polli D; Tedeschi G; Bongarzone I
J Exp Clin Cancer Res; 2018 Apr; 37(1):75. PubMed ID: 29615075
[TBL] [Abstract][Full Text] [Related]
36. The potential of deferasirox as a novel therapeutic modality in gastric cancer.
Choi JH; Kim JS; Won YW; Uhm J; Park BB; Lee YY
World J Surg Oncol; 2016 Mar; 14():77. PubMed ID: 26965928
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of mitochondrial ferritin sensitizes cells to oxidative stress via an iron-mediated mechanism.
Lu Z; Nie G; Li Y; Soe-Lin S; Tao Y; Cao Y; Zhang Z; Liu N; Ponka P; Zhao B
Antioxid Redox Signal; 2009 Aug; 11(8):1791-803. PubMed ID: 19271990
[TBL] [Abstract][Full Text] [Related]
38. Iron depletion decreases proliferation and induces apoptosis in a human colonic adenocarcinoma cell line, Caco2.
Sun X; Ge R; Cai Z; Sun H; He QY
J Inorg Biochem; 2009 Jul; 103(7):1074-81. PubMed ID: 19515424
[TBL] [Abstract][Full Text] [Related]
39. Iron chelation by clinically relevant anthracyclines: alteration in expression of iron-regulated genes and atypical changes in intracellular iron distribution and trafficking.
Xu X; Sutak R; Richardson DR
Mol Pharmacol; 2008 Mar; 73(3):833-44. PubMed ID: 18029550
[TBL] [Abstract][Full Text] [Related]
40. Effects of iron overload condition on liver toxicity and hepcidin/ferroportin expression in thalassemic mice.
Kumfu S; Chattipakorn SC; Fucharoen S; Chattipakorn N
Life Sci; 2016 Apr; 150():15-23. PubMed ID: 26921633
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
